1. Toxicity and Efficacy of ≥4th Line Palbociclib with Endocrine Therapy of Physician's Choice: a Single Centre Experience. Issue 6 (June 2017) Authors: Kingston, B.; Charbouni, N.; Doody, C.; Irfan, T.; Okines, A.; Johnston, S. Journal: Clinical oncology Issue: Volume 29:Issue 6(2017) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Benefit from Vinorelbine after Prior Treatment with Eribulin: a Single-centre Experience. Issue 6 (June 2017) Authors: Irfan, T.; Okines, A.; Khabra, K.; Ring, A.; Parton, M.; Johnson, S.; Turner, N. Journal: Clinical oncology Issue: Volume 29:Issue 6(2017) Page Start: e99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Metaplastic Breast Cancer (MBC): A Single Centre Experience. Issue 6 (June 2018) Authors: Kipps, E.; Irfan, T.; Fribbens, C.; Osin, P.; Nerurkar, A.; Mohammed, K.; Parton, M.; Johnston, S.; Turner, N.; Okines, A. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: e44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Outcomes in Triple-negative Lobular Breast Cancer: a Single-institution Experience. Issue 7 (July 2019) Authors: Irfan, T.; Turkes, F.; Asare, B.; Mohammed, K.; Osin, P.; Nerurkar, A.; Smith, I.; Parton, M.; Johnston, S.; Turner, N.; Okines, A. Journal: Clinical oncology Issue: Volume 31:Issue 7(2019) Page Start: e110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Outcomes in HER2-positive Lobular Breast Cancer: a Single-institution Experience. Issue 7 (July 2019) Authors: Irfan, T.; Asare, B.; Mohammed, K.; Osin, P.; Nerurkar, A.; Smith, I.; Parton, M.; Johnston, S.; Turner, N.; Okines, A. Journal: Clinical oncology Issue: Volume 31:Issue 7(2019) Page Start: e109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗